CLOCK and glioblastoma: Given the circadian clock’s well-documented role in regulating both cell cycle progression and DNA damage response pathways, there exists a compelling biological rationale for timing chemoradiotherapy for GBM, especially for those subtypes resistant to chemoradiation (MES GBM) [24].